Anika Therapeutics (ANIK) Asset Utilization Ratio (2011 - 2026)

Anika Therapeutics (ANIK) has 16 years of Asset Utilization Ratio data on file, last reported at 0.63 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 5.69% year-over-year to 0.63 in Q1 2026; TTM through Mar 2026 was 0.63, a 5.69% increase from a year earlier, with the FY2025 full-year figure at 0.57, up 13.33% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.63, up from 0.59 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for ANIK reached as high as 0.63 in Q1 2026 and fell as low as 0.33 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.46 across 5 years, with a median of 0.43 in 2022.
• Across the five-year window, Asset Utilization Ratio fell 23.22% in 2023 and soared 71.04% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.33 in 2022, then gained by 23.5% to 0.4 in 2023, then jumped by 36.91% to 0.55 in 2024, then advanced by 7.58% to 0.59 in 2025, then grew by 5.85% to 0.63 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.63 in Q1 2026, 0.59 in Q4 2025, and 0.6 in Q3 2025.